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Transmembrane helixCaveolin-1 has a segment of hydrophobic amino acids comprising approximately residues 103–122 that are
anchored to the membrane with cholesterol-rich domains. Previously, we reported that changing the Pro110
residue to Ala (the P110A mutant) prevents not only the localization of the protein into lipid rafts but also the
formation and functioning of caveolae. The conformational state of caveolin-1 can be shifted toward the
transmembrane arrangement by this single amino acid mutation. To model the conformation, and extent
of membrane insertion of this segment into membrane-mimetic environments, we have prepared a peptide
corresponding to this hydrophobic segment of caveolin-1 having the sequence KKKKLSTIFGIPMALIWGIY-
FAILKKKKK-amide and the mutated version, KKKKLSTIFGIAMALIWGIYFAILKKKKK-amide. These peptides
contain ﬂanking Lys residues to facilitate puriﬁcation and handling of the peptide. Circular dichroism mea-
surements demonstrated that the mutated peptide has increased helical content compared with the wild
type both in the presence and absence of lipid. The ﬂuorescence emission from the Trp residues in the peptide
showed signiﬁcant blue shifts in the presence of liposomes, however the presence of cholesterol in hydrated
vesicle bilayers decreases its helical content. Our overall ﬁndings support our studies with the intact protein
in cells and suggest that the peptide of WT caveolin-1 hydrophobic segment has an intrinsic preference not to
maintain its conformation as a rigid transmembrane helix. Substituting the Pro residue with an Ala allows the
peptide to exist in a more hydrophobic environment likely as a consequence of a change in its conformation
to a straight hydrophobic helix that traverses the membrane.hosphocholine; F0, maximum
, and maximum ﬂuorescence
er quenching constant; LPC,
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Caveolae are sphingomyelin and cholesterol rich invaginations (50–
100 nm diameter) in the plasma membrane, that bud inward toward
the cell [1]. They appear to have a number of functions, including roles
in signal transduction [2,3], calcium signaling [4,5], lipid recycling [6,7]
and membrane trafﬁc [1]. Caveolae are particularly prevalent in adipo-
cytes, endothelial cells and myocytes. EGF receptor, PDGF receptor,
membrane estrogen receptor, H-Ras, and extracellular signal regulated
kinase (ERK-1/2), appear to be regulated by their interaction withcaveolae [8–10]. Caveolae and their constituent proteins, caveolins,
have a critical role in cardiovascular function, including regulation of
cholesterol metabolism, nitric oxide synthesis and cardiac function
[11]. Caveolin-1 has also been hypothesized to be an intensive tumor
suppressor, since sporadic mutations of caveolin-1 have been found in
many human cancers [12]. In contrast, caveolin-1 may work as a
tumor promoter in prostate cancer [13]. The involvement of caveolae
in a wide range of disease processes has been suggested [14–17].
One of the features of caveolae is the presence of several forms of the
protein caveolin [18,19]. Caveolin-1 structure has not yet been resolved
by crystallographic analysis. Most experimental evidence indicates that
themembrane-inserting segment of caveolin-1 forms a U-shaped struc-
ture within the membrane having both the N-terminal and C-terminal
domains on the cytoplasmic side of the plasmamembrane [20]. Caveo-
lin-1 is anchored to themembranewith three palmitoyl chains attached
to Cys residues as well as with a hydrophobic segment comprising res-
idues 103–122 [21]. A similar segment comprising residues 102–134
had been previous proposed as the membrane insertion segment [20].
The protein inserts into membranes of phosphatidylcholine in a choles-
terol-dependent manner [22]. This hydrophobic segment is thought to
form a U-shaped, re-entrant helix rather than a transmembrane helix
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region in evolution, suggesting that this segment plays an important
role for caveolin-1 function.
In silico modeling predicts that substituting the Pro110 residue of
caveolin-1 with an Ala will change the conformation to a straight
helix that would traverse the membrane. Furthermore, we found
that the substitution of Pro110 with an Ala inﬂuenced the ability of
caveolae to be endocytosed, and to form lipid droplets indicating
that the multiple activities of caveolin-1 are a consequence of the to-
pology- and compartment-speciﬁc cellular localization of this protein
[21]. In the present study we investigate if the structural preferences
of the isolated hydrophobic segment are responsible for the drastic
topological change caused by this single Pro mutation. We analyzed
the structural tendency of model peptides corresponding to the caveo-
lin-1 hydrophobic segment and a mutant form, using tryptophan ﬂuo-
rescence and circular dichroism in the presence and absence of lipids.
The results provide insights into the functional importance of this seg-
ment in intact caveolin-1 and the role of its Pro residue.
2. Materials and methods
2.1. Materials
LPC, POPC, DPPC and Cholesterol were obtained from Avanti Polar
Lipids (AL, USA). Acrylamide was purchased from Life Technologies
(MD, USA). Chloroform and Methanol were obtained from CALEDON
(ON, Canada). The stock solution of acrylamide (Life Technologies
Inc. MD, USA) was 5 M in ddH2O. Buffers were ﬁltered through an
Acrodisc Syringe Filter (0.2 μm pore size; PALL). Peptides correspond-
ing to the caveolin-1 wild type hydrophobic segment: L103–L122
(WT) and the mutated version of this peptide: L103–P110A–L122
(P110A) were synthesized by SynBioSci (CA, USA), with four Lys res-
idues on the C-terminus, ﬁve Lys residues on the N-terminus and
amidated at the C-terminus. The sequences of the two peptides
were: KKKKLSTIFGIPMALIWGIYFAILKKKKK-amide and the mutated
version, KKKKLSTIFGIAMALIWGIYFAILKKKKK-amide. Peptides were
dissolved in 5 mM Hepes buffer, pH 7.4, 50 mM NaCl (HEPES buffer)
at a concentration of 1 mg/ml. The exact concentration was deter-
mined by absorbance measurements at 280 nm using molar extinction
coefﬁcients based on the Trp and Tyr content of the peptides.
2.2. Preparation of phospholipid small unilamellar vesicles (SUVs)
The desired amount of lipids were dissolved in chloroform and
methanol, 2:1 (v/v), and dried in glass tubes under nitrogen, and fol-
lowed by vacuum for 3 h. Lipid suspensions were prepared by vortex
mixing in HEPES buffer. The lipid ﬁlms were suspended in buffer at
room temperature. Sonication of lipid dispersions was performed in
5 ml glass tubes in a bath-type sonicator (Model 08849–00, Cole-Parmer
Instrument Company, IL, USA) for 5 min (until clear). To avoid degrada-
tion of lipids, sonicationwas performed at ~10 °C under a nitrogen atmo-
sphere. Vesicles were used on the day of preparation.
2.3. Fluorescence titration measurements
Peptide and lipid interactions were studied by monitoring the
changes in the Trp ﬂuorescence emission spectra of the peptides upon
addition of SUVs [25,26]. Intrinsic ﬂuorescence of the Trp residues was
measured using 5 μM solutions of the WT and P110A peptides in
HEPES buffer or after addition of different amounts of lipid vesicles.
Trp ﬂuorescence was measured using a quartz microplate at 25 °C in a
monochromator-based microplate ﬂuorimetry (TECAN SAFAIRE, Tecan
Group Ltd., Männedorf, Switzerland). Excitation wavelength was
295 nm, and emission spectra were recorded from 305 to 450 nm
(5mm excitation bandwidth and 5 mm emission bandwidth). Spectra
were collectedwith a step size of 1 nm. Allmeasurementswere correctedfor light scattering effects by subtraction of background. Background sam-
ples were prepared using the same protocol except HEPES buffer instead
of peptide solution was added. Blue shifts were calculated as the differ-
ence in the wavelength of the maximal emission of the peptide with or
without lipid. 5 μM peptides were used in 200 μM total lipid concentra-
tion giving a maximal lipid-to-peptide ratio of 40.
The extent of peptide burial in the lipid bilayerwas determined from
the intrinsic Trp ﬂuorescence intensity of the peptides in the presence
and absence of SUVs [27–29]. The maximal ﬂuorescence emission in-
tensity of the peptidewas plotted against the added lipid concentration
[30–32]. Data were smoothed by the Adjacent Averagingmethod to the
original ﬂuorescence spectra using Origin 5.0 software.
2.4. Quenching experiments
Peptide and lipid interactions are accompanied by changes in the ac-
cessibility of the peptides to aqueous quenchers of Trp ﬂuorescence in
the presence of SUVs [33]. Acrylamide quenching experiments were
carried out using a 5 μM peptide solution in the absence or presence
of SUVs by addition of aliquots of varying concentrations of acrylamide
[25,26]. Samples were freshly prepared in HEPES buffer. The lipid and
peptide mixtures (molar ratio of 40:1) were incubated for 1 h at room
temperature prior to the measurements. The excitation wavelength was
set at 295 nm instead of 280 nm to reduce the absorbance by acrylamide
and the inner ﬁlter effect. The emission spectra were recorded between
300 and 450 nm after addition of quencher at 25 °C, followed by spectral
correctionby subtracting the spectrameasuredunder identical conditions
but without the peptide. The maximum ﬂuorescence intensities without
and with the quencher (F0 and F respectively) were determined, and F0/
F values were plotted against the acrylamide concentration. The slopes
of the best-ﬁt linear plots were used to determine the Stern–Volmer
quenching constants (KSV). The experimental data were analyzed accord-
ing to the Stern–Volmer equation [34]
F0=Fð Þ ¼ 1þ KSV Q½ : ð1Þ
Data were smoothed by the Adjacent Averaging method to origi-
nal ﬂuorescence spectra using Origin 5.0 software.
2.5. Circular dichroism (CD) spectroscopy
Circular dichroism spectrawere collected using a Circular Dichroism
Spectrometer Model 410 (Aviv Biomedical Inc., NJ, USA). Spectral scans
were performed from 260 to 195 nm, with step resolution of 1.0 nm
and bandwidth of 1.0 nm. A 1-mm-path-length quartz cuvette was
used for the measurements. Freshly prepared samples were measured
at a peptide concentration of 50 μM inHEPES buffer. The secondary struc-
ture of the peptides was determined by applying the Adjacent Averaging
method to the original spectra using the Origin 5.0 software and was an-
alyzed by the CDPro program.
2.6. Reproducibility of spectral measurements
The ﬂuorescence and CD measurements were repeated at least
once, giving similar results. A representative set of data, run at the
same time, is presented. We did not undertake a detailed statistical
analysis of the error because the properties of the two peptides




A model peptide was designed to correspond to the hydrophobic
segment of the mouse caveolin-1 sequence L103–L122. The mean
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(ANTHEPROT 2000V6.0 release 1.1.54) [35]. According to ‘Lys-tag-
ging’ guidelines for synthesis of hydrophobic peptides [36,37], a total
of nine Lys residues were attached to the hydrophobic core sequence
of L103–L122 to produce a water-soluble product. The resulting pep-
tide, designated WT has the sequence KKKK-LSTIFGIPMALIWGIYFAIL-
KKKKK. We also prepared a mutated version of this peptide, designed
P110A, with the sequence KKKK-LSTIFGIAMALIWGIYFAIL-KKKKK. Con-
sistent with previous applications of this hydrophilic tagging approach,
we recognized that the peptide designed in this manner had the beneﬁ-
cial attributes of water solubility and ease of puriﬁcation [36,38,39]. Pre-
vious studies showed that the addition of Lys to hydrophobic peptides
does not prevent them from adopting a stable α-helical conformation
both in solution and in lipid bilayers, furthermore, the number of Lys
residues added does not affect peptide tertiary packing [40–43].
3.2. Fluorescence properties of the WT and P110A peptides in buffer
The ﬂuorescence emission of the twomodel peptideswasmeasured
as a function of peptide concentration in buffer (Fig. 1a). It was found
that the emission intensity was proportional to the peptide concentra-
tion for both peptides (Fig. 1b). This indicates that in buffer the peptides
do not undergo a self-association process that affects the environment of
the Trp residues. In addition, the proportionality between ﬂuorescence
emission intensity and peptide concentration demonstrates the lack of
signiﬁcant inner ﬁlter effects. The ﬂuorescence emission intensity is
greater for the P110A compared with the WT (Fig. 1). In addition, the
wavelength of maximal emission is shifted 8 nm to lower wavelengthsFig. 1. Fluorescence emission spectra of peptides. (a) Fluorescence emission spectra of
WT and P110A in buffer. Peptides concentration was adjusted for 10 μM (WT: ■,
P110A: □), 5 μM (WT: ◆, P110A: ◇), 2 μM (WT: ●, P110A: ○), 1 μM (WT: ▲,
P110A: △). (b) Relative ﬂuorescence intensity at λmax against peptide concentration
(WT: ■, P110A: □). A representative experiment is shown that was repeated twice.
Wavelength accuracy is ±1 nm. The regression coefﬁcients were 0.99 for both WT
and P110A.for the P110A peptide compared with the WT peptide (Fig. 1a). Both
the increased emission intensity and lower ﬂuorescence emission maxi-
mum of the P110A indicate that its Trp residue is in a more hydrophobic
environment, even for the peptide in buffer without the addition of lipid.3.3. Fluorescence properties of the WT and P110A peptides in the pres-
ence of lipids
Measurements of ﬂuorescence emission intensity and shifts in the
λmax of two Trp residues naturally contained in the hydrophobic core of
the peptide are particularly useful for analysis of the insertion/positioning
of eitherWT or P110Awithin themembrane [36,44]. In order to compare
the properties of the peptides in different lipid environments, we used a
range of lipid to peptide molar ratios to assure that sufﬁcient SUVs of
POPC or a micellar solution of LPC were used to cause all of the peptide
to translocate to the lipid (Fig. 2). Cholesterol was also included in one
set of SUVs with the composition PO/DP/Ch, (molar ratio of 1:1:1). The
Trp ﬂuorescence emission spectra of eitherWT or P110Awere measured
either in buffer or in the presence of SUVs and are shown on Fig. 2 at 10:1,
20:1, 40:1 and 80:1 lipid-to-peptide molar ratios. For all of the peptides
and with all of the lipid mixtures used, an increase in the Lipid/Peptide
ratio resulted in an increase in the intensity of the ﬂuorescence emission.
The only exception to this was the wild type peptide in the presence of
SUVs composed of PO/DP/Ch (Fig. 2, panel a-3). In this case increase in
lipid concentration resulted in a decrease in the magnitude of ﬂuores-
cence emission. This may be caused by the lipid causing quenching of
the Trp ﬂuorescence or as a result of these SUVs causing more scattering
and lowering the intensity of both the excitation and emission beams. The
corresponding titration curves were obtained for either WT or P110A by
plotting either the maximal Trp emission wavelength (λmax) (Fig. 2b-1)
or the ﬂuorescence intensity at λmax (Fig. 2 b-2). In the experiments
with SUVs composed of POPC, the P110A peptide shifted the emission
λmax to lower wavelengths, by 8 nm at higher lipid concentrations
(Fig. 2, a-2, b-1). This shift was accompanied by an enhancement of the
emission intensity (Fig. 2, b-2). In contrast, the blue shift of WT was
only 2 nm with POPC at higher peptide concentrations (Fig. 2, b-1).
These results provide evidence of insertion of the P110A into non-polar
environments [44] corresponding to deeper insertion into themembrane
than WT. We also observed a decrease in the blue shift upon addition of
cholesterol to SUVs composed of POPC/DPPC for both WT and P110A
(Fig. 2, b-1). Addition of LPC increased the Trp ﬂuorescence intensity for
P110A more than that for WT (Fig. 2, b-2), but it did not affect λmax.
This indicated that P110Awasmore protected from collisional quenching
by themicelle thanWT, suggesting the greater penetration of P110A into
the micelle. However, the lack of effect of LPC on the emission maximum
of either peptide indicates that amembrane bilayer environment and not
in amicelle is required to increase the hydrophobicity of the environment
of the Trp in P110A.
Additional support for the transfer of Trp ofWT and the P110A from
the aqueous to the membrane environment was obtained from Trp
ﬂuorescence quenching by a water-soluble quencher, acrylamide
[25,26]. Stern–Volmer plots of acrylamide quenching are shown in
Fig. 3, for WT and P110A in buffer and in the presence of SUVs com-
posed of POPC or PO/DP/Ch. The calculated Stern–Volmer constants
(Ksv) are summarized in Table 1. The Stern–Volmer constant (Ksv) is a
measure of the efﬁciency of ﬂuorescence quenching. The two peptides
have similar quenching constants in buffer but the addition of SUVs of
POPC greatly reduces the extent of acrylamide quenching. This protec-
tion by the lipid is somewhat greater for the P110A than for WT again
indicating the greater depth of insertion of P110A into the membrane.
Surprisingly SUVs composed of PO/DP/Ch increase the quenching of
WT. This may reﬂect a greater static quenching component of this pep-
tide in buffer. For both peptides, the lipidmixture PO/DP/Ch contributes
little protection against quenching, suggesting that cholesterol inhibits
penetration of the peptide into the membrane.
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The CD spectra of either WT or P110A were measured in the pres-
ence and absence of two SUVs having two different lipid compositions,
aswell aswith LPCmicelles (Fig. 4, Table 2). All of the sampleswere not
turbid and were visually transparent. Changes in the CD properties of
the peptides caused by the addition of SUVswere comparedwith the ef-
fects of LPC micelles. The LPC micelles are much smaller than SUVs and
consequently do not exhibit light scattering artifacts [45–49]. The CD
spectrum of P110A in buffer, SUVs of POPC or SUV-PO/DP/Ch displayed
a positive maximum at ~195 nm and double minima at ~208 and
~222 nm, indicative of some α-helical character [50]. The addition of
SUVs of POPC caused an increase in the intensity of these maximum
and minimum ellipticities, indicative of higher helical content, as con-
ﬁrmed by deconvolution of the CD spectra (Table 2). The addition of
SUVs composed of PO/DP/Ch decreased in the intensity of theseFig. 2. Fluorescence emission spectra and titration curves of peptideswith lipids. (a) Fluorescen
SUVs; POPC (a-1, 2), PO/DP/Ch (a-3, 4) andmicelle LPC (a-5, 6). The lipid to peptide ratioswere
5 μM. (b) Shift in the (b-1):wavelength ofmaximal Trp emissionwavelength (λmax) and (b-2):
Peptide=1:10. Peptides with different SUVs: POPC (WT:■, P110A:□); PO/DP/Ch (WT: ◆, P11
twice. Wavelength accuracy is ±1 nm.maximum and minimum ellipticities suggesting that peptide insertion
into the bilayerwas inhibited by the presence of cholesterol that caused
tighter packing of the lipid. Percentages of α-helical structure of the
P110A in buffer or in the presence of SUVs of POPC are approximately
1.5–2 times higher than those of WT. In the presence of SUVs of PO/
DP/Ch, likely due to the presence of cholesterol, the insertion of peptide
into SUVs was inhibited and the percentages of α-helical structure of
P110A were smaller. The fraction of α-helical structure found in the
presence of LPC (Table 2) was much greater for LPC than for the SUVs.
The LPC provides a loose environment into which the peptide can pen-
etrate better than the tight packing of the either POPC or PO/DP/Ch bi-
layer. Therefore, the bilayer would prevent complete insertion of the
peptide and make it more difﬁcult to form a full alpha-helix, while
with LPC and the peptide can mix better resulting in more alpha-
helix. In addition, the lack of light scattering artifacts with LPCmay con-
tribute to this increase.ce emission spectra of eitherWT (a-1, 3, 5) or P110A (a-2, 4, 6) peptideswith different lipid
10 (+, purple), 20 (◇, yellow), 40 (▲, blue) and 80 (x, orange). Peptide concentrationwas
theﬂuorescence intensity at λmax relative to the valuemeasured for a samplewith a Lipid:
0A: X); LPC (WT:●, P110A:○). A representative experiment is shown that was repeated
Fig. 2 (continued).
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Caveolin, a 22–24 kDa protein, is an integral membrane protein
component of caveolae membranes. The major lipid components of
caveolae domains are sphingomyelin, phosphatidylcholine and choles-
terol [51]. Many aspects of the hydrophobic segment of caveolin-1,
which is anchored to the membrane by forming a re-entrant helix,
have been studied [22,52–54]. There are several reports about caveolin-
1 being recruited to cholesterol-rich lipid raft domains of membranes.
Cholesterol might increase the thickness of the membrane to accommo-
date the exact lipid environment for incorporation of caveolin or it might
interact with caveolin directly. Research using model peptides indicated
that a segment with the sequence VTKYWFYR that corresponds to a
CRACmotif constituting residues 94–101 (human), promotes the forma-
tion of cholesterol rich domains [54]. This CRAC domain is outside of the
hydrophobic segment studied in the present work. In addition, studies
with caveolin-1 mutants indicate that the segment of residues 82–101
(human) has an important role for membrane binding and has been
called the scaffolding domain [23]. Another feature of the interaction of
caveolin with membranes is that the hydrophobic segment studied in










Fig. 3. Stern–Volmer plots for acrylamide quenching of the Trp ﬂuorescence of the pep-
tides. Peptides in buffer (WT: ■, P110A: □), and in the presence of SUVs composed of
POPC (WT:◆, P110A:◇) and PO/DP/Ch (WT: ●, P110A: ○). Lipids and peptide concen-
tration were, respectively, 200 μM and 5 μM. Linear trend lines were added. This is repre-
sentative data from experiments repeated twice.previous study, we focused on this hydrophobic segment in the intact
caveolin. We reported that membrane topology of the hydrophobic seg-
ment is altered as a consequence of a P110A mutation to become trans-
membrane. This change in membrane topology of the protein prevents
not only the localization of caveolin-1 into cholesterol-rich lipid rafts
but also caveolae formation and functions [21].
The present study was aimed at getting better insight into the con-
tribution of the Pro residue of the isolated hydrophobic segment of
caveolin-1 by the interaction of model peptides and cell membrane-
mimicking phospholipid vesicles. We investigated the ﬂuorescence
properties of the wild type form of this peptide, WT, as well as a corre-
sponding peptide, P110A, with an Ala substituting for Pro. For WT and
P110A in a buffer environment, the Trp residues are highly exposed to
the solvent. Addition of SUVs of POPC results in greater burial of the
Trp of the P110A compared with WT as shown both by the change in
emissionmaximumaswell as a greater decrease in acrylamide quench-
ing. These effects were much less using SUVs of PO/DP/Ch, suggesting
that cholesterol may inhibit penetration of the peptides into the bilayer.
This would suggest that in a cholesterol-rich domain of a biological
membrane this hydrophobic segment would not penetrate deeply
into the bilayer. These changes in Trp ﬂuorescence were in accord
with CD measurements that also indicated greater increases in helicity
of the P110A compared with WT upon addition of lipid and lesser ef-
fects when cholesterol was added. In addition, one of the interesting
ﬁndings is the observation that the Trp residue in the P110A peptide
was sequestered in a more hydrophobic environment than that of the
WT in buffer. The process whereby re-entrant loops partition into the
membrane is largely uncharacterized, and it is not beyond the scope
of possibility that a pre-formed structure in aqueous media might facil-
itate membrane insertion. Such a preformed structure for the P110A
mutant in aqueous media is supported by the ﬂuorescence results
(Fig. 1).Table 1
Stern–Volmer constants Ksv for ﬂuorescence emission quenching of Trp residues in either
WT or P110A peptide incubationwith SUVs. PO, POPC; DP, DPPC; Ch, Cholesterol. A repre-
sentative experiment is shown that was repeated twice. Wavelength accuracy for Absor-
bance/Fluorescence is ±1 nm. Stern–Volmer constants Ksv for ﬂuorescence emission
quenching of Trp residues.
























Fig. 4. Circular dichroism spectra of peptides. Peptides in buffer (WT: ■, P110A: □), in
the presence of SUVs consisting of POPC (WT: ▲, P110A: △) or of PO/DP/Ch (WT: ●,
P110A: ○). Peptide concentration was 50 μM (0.15 mg/ml in buffer), lipid concentra-
tion was 1 mM. This is representative data from experiments repeated twice.
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state of the P110A caveolin-1 hydrophobic segment – ﬂanked by Lys
tags – inserts deeply into bilayer membranes as a structure with a
high α-helical content. A consequence of a single amino acid muta-
tion, substitution of the Pro residue with Ala, results in an increase
of membrane penetration and a higher α-helical content. The results
are in accord with prior studies on the intact caveolin as well as in
silico calculations of the preferred conformations [21].Acknowledgements
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